Variability of glutathione levels in normal breast tissue and subcutaneous fat during the menstrual cycle: An in vivo study with microdialysis technique

被引:36
作者
Dabrosin, C
Ollinger, K
Ungerstedt, U
Hammar, M
机构
[1] LINKOPING UNIV HOSP, FAC HLTH SCI, DEPT PATHOL 2, S-58185 LINKOPING, SWEDEN
[2] KAROLINSKA INST, DEPT PHYSIOL & PHARMACOL, STOCKHOLM, SWEDEN
关键词
D O I
10.1210/jc.82.5.1382
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A small increase in the risk of breast cancer has been reported after long term use of combined estrogen-progestagen treatment. Free oxygen radicals and antioxidants such as glutathione are involved in the regulation of proliferation and apoptosis and thereby in carcinogenesis. To study whether the glutathione levels are sex hormone dependent, we used the microdialysis technique to measure the in vivo concentrations of glutathione in breast tissue and sc fat during the menstrual cycle. Six healthy women (23-32 yr old! were investigated early in the follicular phase and the midluteal phase. Two 60-min fractions each were collected by microdialysis of periumbilical fat and breast tissue, respectively, The samples were stored at -70 C and analyzed by high performance liquid chromatography. Glutathione concentrations increased in the midluteal phase compared to those in the follicular phase in both adipose tissue and breast tissue (P < 0.05). The variability of glutathione levels during the menstrual cycle, with higher levels late in the menstrual cycle, indicates that the antioxidant system could be sex hormone dependent. This may be of importance in breast cancer development.
引用
收藏
页码:1382 / 1384
页数:3
相关论文
共 26 条
[1]   CELL TURNOVER IN THE RESTING HUMAN-BREAST - INFLUENCE OF PARITY, CONTRACEPTIVE PILL, AGE AND LATERALITY [J].
ANDERSON, TJ ;
FERGUSON, DJP ;
RAAB, GM .
BRITISH JOURNAL OF CANCER, 1982, 46 (03) :376-382
[2]   THE RISK OF BREAST-CANCER AFTER ESTROGEN AND ESTROGEN PROGESTIN REPLACEMENT [J].
BERGKVIST, L ;
ADAMI, HO ;
PERSSON, I ;
HOOVER, R ;
SCHAIRER, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :293-297
[3]  
BHARGAVA V, 1994, AM J PATHOL, V145, P535
[4]   ESTROGEN REPLACEMENT THERAPY AND BREAST-CANCER RISK [J].
BRINTON, LA ;
SCHAIRER, C .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) :66-79
[5]   OXIDATIVE STRESS AS A MEDIATOR OF APOPTOSIS [J].
BUTTKE, TM ;
SANDSTROM, PA .
IMMUNOLOGY TODAY, 1994, 15 (01) :7-10
[6]   OXYRADICALS AND CANCER [J].
CERUTTI, PA .
LANCET, 1994, 344 (8926) :862-863
[7]  
CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1
[8]   ROLE OF CELLULAR GLUTATHIONE AND GLUTATHIONE-S-TRANSFERASE IN THE EXPRESSION OF ALKYLATING AGENT CYTOTOXICITY IN HUMAN BREAST-CANCER CELLS [J].
CHEN, G ;
WAXMAN, DJ .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (06) :1079-1087
[9]   Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells [J].
Chiba, T ;
Takahashi, S ;
Sato, N ;
Ishii, S ;
Kikuchi, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (05) :1164-1169
[10]  
Dizdar N, 1991, Melanoma Res, V1, P33, DOI 10.1097/00008390-199104000-00005